Valproic Acid

Grade III Glioma

Virginia Commonwealth UniversitySmall moleculePhase 2Dormant

B

57/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 42/ 100
Competitive Position: 89/ 100

Competitive context

23 Active assets in the Grade III Glioma cohort.

Asset / Sponsor	Phase	Rating
Sorafenib Virginia Commonwealth University	Phase 2	BB
Everolimus Nationwide Children's Hospital	Phase 2	B
Perampanel Mayo Clinic	Phase 4	B
Capecitabine M.D. Anderson Cancer Center	Phase 2	B
Thioguanine Anhydrous M.D. Anderson Cancer Center	Phase 2	B

View all 37 →

Same molecule, other indications

Valproic Acid is also rated in:

bipolar I disorderActive

BBB

Indicative · Phase 4

74 / 100

epilepsyActive

BBB

Indicative · Phase 4

73 / 100

bipolar disorderDormant

BBB

Indicative · Phase 4

73 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.